Pharmacokinetics of amikacin and effect of ascites in Korean patients

American Journal of Health-System Pharmacy

Volumn 59, Issue 19, 2002, Pages 1855-1857

  Kim, Ho Soon ^a   Sohn, In Ja ^a   Min, David I ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CREATININE;

ADULT; AGED; ASCITES; BLOOD ANALYSIS; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; BURN; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEMOGRAPHY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INFUSION; EDEMA; FLUORESCENCE; HUMAN; INFECTION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KOREA; LIVER CIRRHOSIS; MEDICAL RECORD; NOTE; PLEURA EFFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEADY STATE; STUDENT T TEST; TECHNIQUE; UNIVERSITY HOSPITAL;

EID: 0036792016     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.19.1855     Document Type: Note

References (13)

1. Matthews SJ. Aminoglycosides. In: Schumacher JE, ed. Therapeutic drug monitoring. 1st ed. East Norwalk, CT: Appleton & Lange; 1995:237-94.
2. Price KE, DeFuria MD, Pursianno TA. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates. J Infect Dis. 1976; 134:S249-61.
3. Clarke JT, Libke RD, Regamey C et al. Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther. 1974; 15:610-6.
4. Zaske DE, Strate RG, Kohls PR. Amikacin pharmacokinetics: wide interpatient variation in 98 patients. J Clin Pharmacol. 1991; 31:158-63.
5. Pechere JC, Dugal R. Clinical pharmacokinetics of aminoglycoside antibiotics. Clin Pharmacokinet. 1979; 4:170-99.
6. Bodey GP, Valdivieso M, Feld R et al. Pharmacology of amikacin in humans. Antimicrob Agents Chemother. 1974; 5:508-12.
7. Mann HJ, Fuhs DW, Awang R et al. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm. 1987; 6:148-53.
8. Dasta JF, Armstrong DK. Variability in aminoglycoside pharmacokinetics in critically ill surgical patients. Crit Care Med. 1988; 16:327-30.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.
10. Sawchuk RJ, Zaske DE, Cipolla RJ et al. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther. 1977; 21:362-9.
11. Lanao JM, Dominguez-Gil A, Macias JG. The influence of ascites on the pharmacokinetics of amikacin. Int J Clin Pharmacol Ther Toxicol. 1980; 18(2):57-61.
12. Sampliner R, Perrier D, Dowell R. Influence of ascites on tobramycin pharmacokinetics. J Clin Pharmacol. 1984; 24(1):43-6.
13. Gill MA, Kern JW. Altered gentamicin distribution in ascites patients. Am J Hosp Pharm. 1979; 36:1704-6.